BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8469362)

  • 1. [Screening for ovarian carcinoma].
    Broso P; Buffetti G
    Minerva Ginecol; 1993; 45(1-2):31-7. PubMed ID: 8469362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of transvaginal ultrasonography in the screening of ovarian tumors].
    De Rosa G; Catalano D; Dell'Isola A; Sarnataro C; Cerrone M
    Minerva Ginecol; 1997 Jun; 49(6):243-9. PubMed ID: 9289662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any value in bimanual pelvic examination as a screening test.
    Grover SR; Quinn MA
    Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive look at the early detection of ovarian cancer.
    O'Rourke J; Mahon SM
    Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer. The most lethal gynecologic malignancy.
    Brucks JA
    Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospectively detected cancer in familial breast/ovarian cancer screening.
    Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian carcinoma.
    Granberg S; Wikland M
    J Ultrasound Med; 1988 Feb; 7(2):59-64. PubMed ID: 3279225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound screening in women at risk for ovarian cancer.
    Andolf E
    Clin Obstet Gynecol; 1993 Jun; 36(2):423-32. PubMed ID: 8513636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for ovarian cancers: critical analysis].
    Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
    Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on tumor markers at the second screening].
    Sato S; Sugo T; Maruyama H; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1247-53. PubMed ID: 7844443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study of a randomised trial of ovarian cancer screening.
    Tabor A; Jensen FR; Bock JE; Høgdall CK
    J Med Screen; 1994 Oct; 1(4):215-9. PubMed ID: 8790522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.